{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:17:57Z","timestamp":1794712677787,"version":"4.9.1"},"reference-count":35,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2021_CS.23"],"award-info":[{"award-number":["2021_CS.23"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Project-ID 375876048 \u2013 TRR 241"],"award-info":[{"award-number":["Project-ID 375876048 \u2013 TRR 241"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZU 377\/4-1"],"award-info":[{"award-number":["ZU 377\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therap Adv Gastroenterol"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>There is an increasing diversification in the treatment landscape for inflammatory bowel diseases (IBD) leading to therapeutic challenges that can only incompletely be covered by prospective randomized double-blind trials. Real-world observations are therefore an important tool to provide insights into therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To describe the real-world treatment algorithms in an IBD referral centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Single-centre retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively analysed prospectively collected data on treatment sequences and outcomes from 502 patients with Crohn\u2019s disease (CD) and ulcerative colitis (UC) treated with infliximab, adalimumab, vedolizumab or ustekinumab at a large German tertiary referral centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Treatment decisions correlated to baseline patient characteristics. Over time, infliximab continued to be the preferred first-line option in CD and UC, although ustekinumab and vedolizumab, respectively, became increasingly important choices. Remission rates decreased with the advancement of therapy lines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We provide insights into the evolution of tertiary centre real-world treatment sequences that might \u2013 together with other observations \u2013 help to guide the selection of therapies in IBD. Our data also strongly underscore the unmet need for biomarkers supporting treatment decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562848241284051","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T03:26:23Z","timestamp":1727493983000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience"],"prefix":"10.1177","volume":"17","author":[{"given":"Kim","family":"Wagner","sequence":"first","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2768-277X","authenticated-orcid":false,"given":"Tanja M.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vitali","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-643X","authenticated-orcid":false,"given":"Sarah","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Haberkamp","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rouse-Merkel","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-8433","authenticated-orcid":false,"given":"Raja","family":"Atreya","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F.","family":"Neurath","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-2784","authenticated-orcid":false,"given":"Sebastian","family":"Zundler","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, Friedrich-Alexander University Erlangen-Nuremberg, Ulmenweg 18, Erlangen, D-91054, Germany"},{"name":"Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"bibr1-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215739"},{"key":"bibr2-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215734"},{"key":"bibr3-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602773"},{"key":"bibr4-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900750"},{"key":"bibr5-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606910"},{"key":"bibr6-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00666-8"},{"key":"bibr7-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00581-5"},{"key":"bibr8-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212728"},{"key":"bibr9-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033617"},{"key":"bibr10-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207940"},{"key":"bibr11-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00467-6"},{"key":"bibr12-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0228-5"},{"key":"bibr13-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905725"},{"key":"bibr14-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00688-2"},{"key":"bibr15-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314585"},{"key":"bibr16-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3462"},{"key":"bibr17-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2017.04.010"},{"key":"bibr18-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318343"},{"key":"bibr19-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"bibr20-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00377-0"},{"key":"bibr21-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.02.016"},{"key":"bibr22-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001039"},{"key":"bibr23-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.236"},{"key":"bibr24-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad245"},{"key":"bibr25-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad203"},{"key":"bibr26-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2023.2230126"},{"key":"bibr27-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17616"},{"key":"bibr28-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac271"},{"key":"bibr29-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231201728"},{"key":"bibr30-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16436"},{"key":"bibr31-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1111\/apt.18006"},{"key":"bibr32-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01604-z"},{"key":"bibr33-17562848241284051","author":"Bokemeyer B","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"bibr34-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.01.038"},{"key":"bibr35-17562848241284051","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00466-4"}],"container-title":["Therapeutic Advances in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848241284051","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562848241284051","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562848241284051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T18:33:01Z","timestamp":1740853981000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562848241284051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"alternative-id":["10.1177\/17562848241284051"],"URL":"https:\/\/doi.org\/10.1177\/17562848241284051","relation":{},"ISSN":["1756-2848","1756-2848"],"issn-type":[{"value":"1756-2848","type":"print"},{"value":"1756-2848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"article-number":"17562848241284051"}}